The 13th Annual BIO Investor Forum assembles a select group of early- and late- stage companies, established and emerging public biotechs, and top public and private equity investors to explore investment trends and opportunities in life sciences. Since 2011, 44% of all US therapeutic IPO companies participated in a BIO Investor Forum event as a private company!
In addition to expert-led workshops, panel discussions, and fireside chats focusing on industry trends, the conference features presentations by over 100 biotech companies poised to join the growth “watch list” in 2015, as well as a number of nonprofit and venture philanthropy organizations. Organizations who are interested in presenting can submit an application here, and will be contacted within two business weeks about their presentation status.
Now a staple at the Investor Forum, the 13th annual event will once again feature a series of Discovery Track presentations. A pricing level has been created for "pre-emerging" biotech companies wishing to participate in the BIO Investor Form. The presentations will focus on Seed and A-round companies incorporated after 2009 that have raised less than $25M total through October 2014. Companies in this track are also first-time presenters at this event and use biotechnology or related technologies for research and development of drug products or diagnostics. The typical audience for all presentations features public and private equity investors, research analysts, investment bankers and industry executives.
For any questions regarding company presentations, contact Jennifer Fernandez at email@example.com.